Post-Osimertinib Treatment Options for EGFR+ NSCLC - Targeted Therapies in Lung Cancer 2023

Описание: Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This includes a Q&A with the audience and a presentation by a patient advocate, Ivy Elkins.

In this video, Dr. Isabel Preeshagul discusses options for EGFR+ NSCLC treatment after Osimertinib.

View transcript here: https://drive.google.com/file/d/1gm3I...

For more, please visit http://cancerGRACE.org/.
To join the conversation, visit https://cancergrace.org/forum.

BenSound File Name: Sweet (BenSound.com)
BenSound License #: DSSHUIYGV4VQCETM

Thank you to our sponsors: #Takeda #Janssen #Lilly #Genentech #Mirati #ExactSciences #BMS #GEHealthcare.